JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Internal Medicine Section DOI : 10.7860/JCDR/2015/14918.6491
Year : 2015 | Month : Sep | Volume : 9 | Issue : 9 Full Version Page : OD01 - OD02

Therapeutic Hypothermia after Prolonged Cardiac Arrest: Case Report with Review of Literature

Gautam Rawal1, Sankalp Yadav2, Nitin Garg3

1 Attending Consultant-Critical Care, Rockland Hospital, Qutab Institutional Area, New Delhi, India.
2 General Duty Medical Officer-II, Chest Clinic, Moti Nagar, New Delhi, India.
3 Senior Consultant and Head-Critical Care, Rockland Hospital, Qutab Institutional Area, New Delhi, India.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Dr. Gautam Rawal, Flat No. 417, Dhruva Apartments, Plot No. 4, I P Extension, Patparganj, Delhi-110092, India.
E-mail: drgautamrawal@hotmail.com
Abstract

Patients who survive cardiac arrest often develop severe neurological dysfunction due to the hypoxic brain injury and reperfusion induced cell death. Therapeutic hypothermia (TH) has become a standard therapy of cerebral protection following the successful return of spontaneous circulation in patients of out-of-hospital cardiac arrest, according to American heart association guidelines. This is a case report of a 30-year-old patient who developed in-hospital cardiac arrest and was revived after prolonged cardiopulmonary resuscitation (CPR) and also required primary angioplasty. TH was then established with local measures for 24 hours for cerebral protection. The patient was gradually and successfully weaned off from ventilator with no neurological impairment. There is an increasing evidence of TH and its protective mechanisms in patients with non-shockable arrest rhythms with particular emphasis on neurological outcomes. This article emphasizes the role of TH in every successful CPR irrespective of the cardiac rhythm.

Keywords

Case Report

A 30-year-old male was presented to the emergency with the complaint of severe epigastric pain. In the emergency department the patient suddenly collapsed and went into an asystolic cardiac arrest. Code blue was announced and the patient was revived after a prolonged CPR for 50 minutes, without any shockable rhythm. The patient was unresponsive and had fixed dilated pupils after return of spontaneous circulation (ROSC). His electrocardiogram (ECG) showed ST elevation myocardial infarction in anterolateral leads [Table/Fig-1]. He was immediately shifted to the Cath lab for primary percutaneous transluminal coronary angioplasty (PTCA) and found to have significant (90%) occlusion of left anterior descending (LAD) coronary artery and a stent was inserted and then shifted to medical ICU. TH was started in the ICU without delay with cold saline infusion and surface cooling with water, ice packs in axilla and groin and fan to target temperature of 32oC to 34oC. With the start of TH, arterial blood pressure dropped to 90/50mmHg with heart rate 90 per minute and as per protocol adrenaline infusion was started to aim a mean arterial pressure of 80mmHg. The patient was also started on sedation with intravenous midazolam and fentanyl. TH was continued for 24 hours and then gradually re- warming was done at a rate of 0.5oC per hour. There were no major electrolyte changes, shivering or arrhythmias during TH and re-warming. Sedation was discontinued and the patient regained his consciousness with good neurological recovery. The patient was successfully weaned off from the ventilator the next day without any neurological deficit.

ECG showing ST elevation myocardial infarction in anterolateral leads (1,aVL,V2-6)

Discussion

Therapeutic hypothermia (TH) refers to the targeted temperature management of the patient surviving cardiac arrest, in which the body temperature is lowered so as to reduce the risk of tissue and neuronal injury due to lack of blood flow initially and then from reperfusion [1,2].

The benefits and knowledge of TH in post cardiac arrest survivor are proven in the setting of critical care [16]. The practice of TH has remained limited despite this, especially in the developing countries, including India, where there are no established guidelines following CPR. This may be also partly due to the lack of awareness among the clinicians that this practice is still underutilized. Good neurological outcomes are desired, but difficult to achieve post cardiac arrest. The few hours post ROSC and also during the CPR itself is aimed at achieving this goal of cerebral preservation. The aim of presenting this case is to emphasize and encourage the timely use of the potential benefits of TH which may be applied also in non-shockable cardiac arrest with prolonged arrest period and not only in Ventricular Fibrillation (VF)/Ventricular Tachycardia (VT) [16].

Neurologic injury is the most common cause of death in patients with out-of-hospital cardiac arrest and contributes to the high mortality and morbidity of in-patients with cardiac arrest who regain spontaneous circulation [7,8]. When combined with a standard post-cardiac arrest care, lowering core body temperature to the range of 32oC to 34°C during the first hours after cardiac arrest improves neurologic outcome compared to not controlling body temperature [1]. A large randomized trial reports similar improvements in outcome whether the temperature is maintained at 33°C or 36°C [9]. An increase in mortality of about 20% has been associated with every hour delay in initiation of hypothermia [2,6].

The American heart association (AHA) guidelines 2010 for post cardiac arrest care has emphasized on the use of therapeutic hypothermia as a neuro-protective therapy in adult post-cardiac arrest victims whose initial cardiac rhythm is (VF/VT) and who remain comatose (GCS<8) after ROSC (class I; Level B) [10,11]. The evidence of TH effectiveness after asystole or PEA is considered doubtful (class IIb; level C) [1012]. Hyperthermia following cardiac arrest has been found to be associated with worse neurologic outcome [13].

There are four phases during the post-cardiac arrest: phase one includes the period immediately after ROSC up to 20 minutes. It is characterized by cardiovascular dysfunction, with a corresponding 63% mortality. The second or the intermediate phase- 20 minutes to 6-12 hours, post ROSC there is neurological and other organ damage and being the cause of morbidity at discharge. The third phase (from 6-12 hours to 72 hours) requires aggressive management as the post ROSC injury pathways are still active. Finally, the recovery phase–post 72 hours accounts for the mortality from infectious complications, and multiple organ failure.

The neuro-protective mechanism of TH is attributed to [3,4,14]:

6–10% reduction in cerebral metabolism per every degree Celsius of temperature drop;

prevention from the cytotoxic cascade caused by free oxygen radicals;

decreased apoptosis between 48 and 72 after the arrest;

decreases cerebral inflammatory response;

blood–brain barrier protection.

Hypothermia can be achieved by either internal or external methods. Internal methods include intravenous fluids like normal saline cooled to 4oC or the endovascular cooling catheters. The external cooling methods include ice packs placed in the groin, armpits, neck or the use of cooling blankets [3,8]. Shivering is a common response to hypothermia (most commonly occurs during induction of TH) and may cause disruption of the therapy due to heat production. Shivering may be abolished by using sedatives with or without neuromuscular blockade [3].

Hypothermia can produce several detrimental effects which can adversely affect the outcome of the patient [1,2]. TH may lead to increased blood viscosity causing deep vein thrombosis, impaired coagulation leading to bleeding diathesis, reduced cardiac output or arrhythmias, increased susceptibility to infection (especially pulmonary), cold induced diuresis leading to dyselectrolytemias (hypokalemia) and metabolic disturbances like hyperglycaemia.

Continuous temperature monitoring should be done to avoid fluctuations in temperature. Re-warming should be done slowly at a rate of about 0.5°C per hour. Research has shown that the TH is not only helpful in post-cardiac arrest, but may have a crucial role in various other cerebral insults like traumatic brain injury or stroke, where the mechanism of neuronal injury is essentially similar [15].

Conclusion

This case of cardiac arrest followed by therapeutic hypothermia emphasizes the advantages of TH on patient’s neurological outcome. The ease of its administration and positive clinical outcome should encourage everyone to avail this modality by incorporating it in their institutional guidelines so that it may be initiated in a timely manner.

The authors also suggest that TH should be considered and initiated in every successful cardiopulmonary resuscitation irrespective of the type of arrest.

References

[1]Arrich J, Holzer M, Havel C, Müllner M, Herkner H, Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation Cochrane Database Syst Rev 2012 9:CD004128  [Google Scholar]

[2]Scirica BM, Therapeutic Hypothermia After Cardiac Arrest Circulation 2013 127:244-50.  [Google Scholar]

[3]Geocadin RG, Koenig MA, Jia X, Stevens RD, Peberdy MA, Management of brain injury after resuscitation from cardiac arrest Neurol Clin 2008 26(2):487-506.  [Google Scholar]

[4]The Hypothermia after Cardiac Arrest Study GroupMild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest N Engl J Med 2002 346:549-46.  [Google Scholar]

[5]Lucas JM, Cocchi MN, Salciccioli J, Stanbridge JA, Geocadin RG, Herman ST, Neurologic recovery after therapeutic hypothermia in patients with post-cardiac arrest myoclonus Resuscitation 2012 83(2):265-69.  [Google Scholar]

[6]Mooney MR, Unger BT, Boland LL, Burke MN, Kebed KY, Graham KJ, Therapeutic hypothermia after out-of-hospital cardiac arrest: evaluation of a regional system to increase access to cooling Circulation 2011 124(2):206-14.  [Google Scholar]

[7]Laver S, Farrow C, Turner D, Nolan J, Mode of death after admission to an intensive care unit following cardiac arrest Intensive Care Med 2004 30(11):2126-28.  [Google Scholar]

[8]Zahid MM, Siddiqui RS, Noureldin AH, Intact neurological status after induced therapeutic hypothermia in cardiac arrest Case Rep Int 2014 3:10-13.  [Google Scholar]

[9]Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C, Targeted temperature management at 33°C versus 36°C after cardiac arrest N Engl J Med 2013 369:2197-206.  [Google Scholar]

[10]Neumar RW, Otto CW, Link MS, Kronick SL, Shuster M, Callaway C, 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science Circulation 2010 122:S729-67.  [Google Scholar]

[11]Peberdy MA, Callaway CW, Neumar RW, Geocadin RG, Zimmerman JL, Donnino M, Part 9: Post cardiac arrest care: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care Circulation 2010 122:S768-86.  [Google Scholar]

[12]Kim YM, Yim HW, Jeong SH, Klem ML, Callaway CW, Does therapeutic hypothermia benefit adult cardiac arrest patients presenting with non-shockable initial rhythms? A systematic review and meta-analysis of randomized and non-randomized studies Resuscitation 2012 17:188-96.  [Google Scholar]

[13]Gebhardt K, Guyette FX, Doshi AA, Callaway CW, Rittenberger JC, Prevalence and effect of fever on outcome following resuscitation from cardiac arrest Resuscitation 2013 84(8):1062-67.  [Google Scholar]

[14]Ambrosio G, Zweier JL, Flaherty JT, The relationship between oxygen radical generation and impairment of myocardial energy metabolism following post ischemic reperfusion J Mol Cell Cardiol 1991 23(12):1359-74.  [Google Scholar]

[15]Polderman KH, Application of therapeutic hypothermia in the intensive care unit. Opportunities and pitfalls of a promising treatment modality-part 2: Practical aspects and side effects Intensive Care Med 2004 30:757-69.  [Google Scholar]